Connection

Denis Guttridge to Drug Administration Schedule

Back to Details
This is a "connection" page, showing publications Denis Guttridge has written about Drug Administration Schedule.
Denis Guttridge
Connection Strength
0.025
Drug Administration Schedule
  1. Disrupting cytokine signaling in pancreatic cancer: a phase I/II study of etanercept in combination with gemcitabine in patients with advanced disease. Pancreas. 2013 Jul; 42(5):813-8.
    View in: PubMed
    Score: 0.025
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.